chr7-116553675-T-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001753.5(CAV1):c.196-5271T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.264 in 152,010 control chromosomes in the GnomAD database, including 5,432 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5432 hom., cov: 32)
Consequence
CAV1
NM_001753.5 intron
NM_001753.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.46
Publications
17 publications found
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- partial lipodystrophy, congenital cataracts, and neurodegeneration syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- pulmonary hypertension, primary, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital generalized lipodystrophy type 3Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CAV1 | NM_001753.5 | c.196-5271T>A | intron_variant | Intron 2 of 2 | ENST00000341049.7 | NP_001744.2 | ||
| CAV1 | NM_001172895.1 | c.103-5271T>A | intron_variant | Intron 2 of 2 | NP_001166366.1 | |||
| CAV1 | NM_001172896.2 | c.103-5271T>A | intron_variant | Intron 1 of 1 | NP_001166367.1 | |||
| CAV1 | NM_001172897.2 | c.103-5271T>A | intron_variant | Intron 2 of 2 | NP_001166368.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.264 AC: 40096AN: 151892Hom.: 5429 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40096
AN:
151892
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.264 AC: 40131AN: 152010Hom.: 5432 Cov.: 32 AF XY: 0.263 AC XY: 19568AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
40131
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
19568
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
13138
AN:
41438
American (AMR)
AF:
AC:
3412
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
864
AN:
3468
East Asian (EAS)
AF:
AC:
1129
AN:
5142
South Asian (SAS)
AF:
AC:
1252
AN:
4814
European-Finnish (FIN)
AF:
AC:
2947
AN:
10576
Middle Eastern (MID)
AF:
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16524
AN:
67978
Other (OTH)
AF:
AC:
539
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1525
3050
4574
6099
7624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
749
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.